|
Loop diuretic treatment: time for new options
|
№3 / 2009
|
|
V.A. Kokorin, M.V. Kokorina
Problems of nephrology in 100-year history of Russian Scientific Medical Society of Internists
|
№3 / 2009
|
|
|
№2 / 2009
|
|
Membranous nephropathy: how to differentiate primary and paraneoplastic variants?
|
№2 / 2009
|
|
Optimization of loop diuretic therapy in chronic heart failure and chronic kidney disease
|
№2 / 2009
|
|
M.Yu. Shvetsov, MD, PhD; A.A. Ivanov, MD, PhD, Prof; O.P. Popova, MD; A.V. Kuznetsova, MD, PhD; A.S. Rameeva
Renal expression of hypoxia-induced factor-1, anemia and nephrosclerosis severity in chronic glomerulonephritis.
|
№2 / 2009
|
|
L.T. Pimenov, MD, PhD, Prof; M.V. Dudarev, MD, PhD; M.Yu. Vasil’ev, MD
Chronic kidney disease as an outcome of hemorrhagic fever with renal syndrome
|
№2 / 2009
|
|
V.V. Rameev, MD; L.V. Kozlovskaya, MD, PhD, Prof; E.A. Malinina, A.G. Serova, I.N. Kogarko, MD, PhD; B.S. Kogarko, MD, PhD; N.V. Liubimova, MD, PhD
Determination of circulating amyloid precursor protein in diagnosis and monitoring of disease progression in systemic amyloidosis
|
№2 / 2009
|
|
I.E. Chazova, MD, PhD, Prof; V.V. Fomin, MD, PhD; M.A. Razuvaeva, MD; A.V. Vigdorchik, MD
Russian registry of resistant arterial hypertension (“REGATTA”): study design.
|
№2 / 2009
|
|
G.P. Arutyunov, MD, PhD, Prof; L.G. Oganezova, MD
Beta-blockers and renal continuum
|
№2 / 2009
|
|
E.M. Paltseva, MD, PhD
Experimental models of chronic nephropathies
|
№2 / 2009
|
|
S.V. Moiseev, MD, PhD, Prof; G.P. Arutyunov, MD, PhD, Prof; V.V. Fomin, MD, PhD
ACE inhibitors and nephroprotection in chronic proteinuric nephropathies
|
№2 / 2009
|
Русский
